17 completed, 6 recruiting, 6 unknown, 3 terminated. 38 Phase 2, 12 Phase 1, 4 Phase 3.
Follow FMT: new trials by email Literature Review of FMT trials Research Report on FMT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ecosystem Nourishment for Gut Restoration After Fecal Transplantation Fecal Microbiota Transplant Capsules, Microbiome Rejuvenating Diet, Placebo Fecal Microbiota Transplantation - Aging | Phase 2 | Not yet recruiting | Stanford University | 80 | 2026-12-01 | 2026-09-17 |
| Evaluation of the Outcome of Fecal Microbiota Transplantation Fecal Microbiota Transplantation, FMT Matched Placebo, Rifaximin、Lactulose - Hepatic Encephalopathy, Fecal Microbiota Transplantation | Phase 1 / Phase 2 | Not yet recruiting | Air Force Military Medical University, China | 40 | 2026-03-07 | 2026-03-06 |
| Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells Axicabtagene Ciloleucel, Biospecimen Collection, Chemotherapy - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements | Phase 2 | Recruiting | City of Hope Medical Center | 56 | 2026-02-11 | 2026-03-05 |
| Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA) Fecal microbiota transfer, Vancomycin Oral Capsule, Atezolizumab + Bevacizumab - Immunotherapy, HCC - Hepatocellular Carcinoma | Phase 2 | Recruiting | Michael Dill | 48 | 2025-07-16 | 2025-08-06 |
| Fecal Microbiota Transplantation in Axial Spondyloarthritis FMT, Placebo - Axial Spondyloarthritis, Ankylosing Spondylitis | Phase 2 | Recruiting | University Hospital of North Norway | 99 | 2024-06-01 | 2026-08-14 |
| The Efficacy and Safty of FMT in Patients With CID fecal microbiota, Placebo, synbiotics - Insomnia Chronic, Fecal Microbiota Transplantation | Phase 1 / Phase 2 | Completed | Peking University Sixth Hospital | 80 | 2023-10-08 | 2026-02-27 |
| Superdonor FMT in Patients With Ulcerative Colitis FMT, Placebo FMT - Active Ulcerative Colitis | Phase 1 / Phase 2 | Recruiting | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 42 | 2023-02-13 | 2026-03-19 |
| Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis Fecal Microbiota Transplantation, Placebo - Alcoholic Hepatitis | Phase 1 / Phase 2 | Unknown | Prasun Kumar Jalal | 50 | 2023-01-21 | 2025-01-23 |
| Microbial Restoration in Inflammatory Bowel Diseases Antibiotics, Dietician designed diet, FMT - Fecal Microbiota Transplantation, Crohn Disease | Phase 1 / Phase 2 | Recruiting | St Vincent's Hospital Melbourne | 120 | 2022-05-01 | 2025-02-26 |
| Neurocognitive Effects of FMT in MDD Patients With and Without IBS Fecal Microbiota Transplantation - Major Depressive Disorder, Irritable Bowel Syndrome | Phase 2 / Phase 3 | Active not recruiting | Valerie Taylor | 133 | 2022-04-06 | 2026-03-19 |
| Faecal Microbiota Transplantation for Liver Cirrhosis Faecal microbiota transplantation, Placebo - Liver Cirrhosis | Phase 2 / Phase 3 | Recruiting | University of Aarhus | 220 | 2021-07-01 | 2025-01-24 |
| Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae FMT - Carbapenem-Resistant Enterobacteriaceae Infection | Phase 2 / Phase 3 | Completed | Rambam Health Care Campus | 15 | 2021-04-01 | 2022-10-26 |
| Fecal Microbiota Transplant and Re-introduction of Anti-PD-1 Therapy (Pembrolizumab or Nivolumab) for the Treatment of Metastatic Colorectal Cancer in Anti-PD-1 Non-responders Biopsy, Fecal Microbiota Transplantation, Fecal Microbiota Transplantation Capsule - Metastatic Colorectal Adenocarcinoma, Metastatic Small Intestinal Adenocarcinoma | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 15 | 2021-02-22 | 2026-06-12 |
| Fecal Microbiome Transplantation (FMT) in Pediatric Patients Colonized With Antibiotic-resistant Pathogens Before Hematopoietic Stem Cell Transplantation (HSCT) FMT - Antibiotic Resistant Strain | Phase 2 | Unknown | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 15 | 2020-12-15 | 2020-12-01 |
| Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae FMT - Carbapenem-Resistant Enterobacteriaceae Infection | Phase 2 / Phase 3 | Completed | Rambam Health Care Campus | 3 | 2020-10-12 | 2022-11-29 |
| Transfer of Feces in Ulcerative Colitis 2 Fecal microbiota transplant - Ulcerative Colitis, Ulcerative Colitis Flare | Phase 2 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 85 | 2020-06-12 | 2026-03-20 |
| Fecal Transplant +/- Gut Decontamination in Preventing Acute Graft Versus Host Disease in Patients Given Broad-Spectrum Antibiotics Best Practice, Fecal Microbiota Transplantation, Nystatin - Graft-versus-host Disease Prevention | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2020-06-01 | 2020-03-04 | |
| Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis Fecal Microbiota Transplantation, Psyllium Husk Powder - Ulcerative Colitis, Inflammatory Bowel Diseases | Phase 2 | Completed | Weill Medical College of Cornell University | 27 | 2020-01-31 | 2025-01-03 |
| ICON-2: FMT and Bezlotoxumab Compared to FMT and Placebo for Patients With IBD and CDI Bezlotoxumab, Placebo, Fecal Microbiota Transplantation - Inflammatory Bowel Diseases, Clostridium Difficile Infection | Phase 2 | Completed | Brigham and Women's Hospital | 61 | 2020-01-01 | 2025-12-09 |
| Clinical Trial to Evaluate the Efficacy of Fecal Microbiota Transplantation in Patients With Alopecia Areata Fecal material transfer therapy, 4mm Punch Biopsy of Scalp, Blood draw - Alopecia Areata, Alopecia Totalis | Phase 2 | Withdrawn | Lindsey Bordone | 2019-12-19 | 2022-03-21 |
Showing 20 of 38. Sign in to see all of them.
Colitis, Ulcerative (6) · Inflammatory Bowel Diseases (6) · Crohn Disease (5) · Clostridium Infections (4) · Hepatic Encephalopathy (3) · Obesity (3) · Dysbiosis (2) · Hepatitis, Alcoholic (2) · Metabolic Syndrome (2) · Alopecia (1) · Alopecia Areata (1) · Alopecia universalis (1) · Anxiety Disorders (1) · Arthritis (1) · Ascites (1)
University of Alberta (4) · Brigham and Women's Hospital (3) · M.D. Anderson Cancer Center (2) · Rambam Health Care Campus (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Air Force Military Medical University, China (1) · Boston Medical Center (1) · Children's Hospital Los Angeles (1) · City of Hope Medical Center (1) · Colleen Kelly (1) · Endeavor Health (1) · Federal Research Institute of Pediatric Hematology, Oncology and Immunology (1) · First Affiliated Hospital of Chengdu Medical College (1) · Fondazione Policlinico Universitario Agostino Gemelli IRCCS (1) · Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal (1)
United States (17) · Canada (5) · China (4) · Israel (2) · Australia (1) · Czechia (1) · Denmark (1) · Germany (1) · Italy (1) · Netherlands (1) · Norway (1) · Russia (1) · Spain (1)
Dina Kao, MD (2) · Jessica R Allegretti, MD, MPH (2) · Karen Madsen, PhD (2) · Sonia Michail, MD (2) · Amin M Alousi (1) · Armin Rashidi, MD, PhD (1) · Becky Smith, MD (1) · Christopher C Thompson, MD, MSC (1) · Colleen R Kelly, MD (1) · Dongfeng Chen, doctor (1) · Feifei WU (1) · Gianluca Ianiro (1)
PMID 22265264, PMID 27547925, PMID 29100842, PMID 29615661, PMID 30480772, PMID 31301451, PMID 32173258, PMID 32433595, PMID 33420959, PMID 33602945, PMID 34226737, PMID 35313729, PMID 37235836, PMID 38109364, PMID 39530534, PMID 39938959, PMID 40254304, PMID 40460824, PMID 40930564, PMID 42026772, PMID 42086265
P30CA016672 (1), P30CA033572 (1), P50CA221707 (1), R01DK128257 (1)